SELLAS Life Sciences (SLS) Other Non-Current Assets (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Other Non-Current Assets for 9 consecutive years, with $43000.0 as the latest value for Q3 2024.
- On a quarterly basis, Other Non-Current Assets fell 88.59% to $43000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $43000.0, a 88.59% decrease, with the full-year FY2023 number at $275000.0, down 31.08% from a year prior.
- Other Non-Current Assets was $43000.0 for Q3 2024 at SELLAS Life Sciences, down from $270000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $687000.0 in Q2 2020 to a low of $43000.0 in Q3 2024.
- A 5-year average of $470052.6 and a median of $514000.0 in 2022 define the central range for Other Non-Current Assets.
- Peak YoY movement for Other Non-Current Assets: soared 502.63% in 2020, then plummeted 88.59% in 2024.
- SELLAS Life Sciences' Other Non-Current Assets stood at $614000.0 in 2020, then dropped by 3.26% to $594000.0 in 2021, then crashed by 32.83% to $399000.0 in 2022, then crashed by 31.08% to $275000.0 in 2023, then plummeted by 84.36% to $43000.0 in 2024.
- Per Business Quant, the three most recent readings for SLS's Other Non-Current Assets are $43000.0 (Q3 2024), $270000.0 (Q2 2024), and $272000.0 (Q1 2024).